The digital breast tomosynthesis equipment market has witnessed significant growth over the past few years owing to the various advantages offered by DBT over conventional 2D mammography. Digital breast tomosynthesis (DBT) is an advanced form of breast imaging that uses low-dose X-rays and computer reconstruction to create three-dimensional (3D) images of the breasts. Compared to 2D mammography, DBT provides improved visualization of the breast tissue and enhances the detection of subtle cancers by reducing the obscuring effects of overlapping tissue. It has better sensitivity in women with dense breasts and allows for detection of smaller cancers.

The Global Digital Breast Tomosynthesis Equipment Market is estimated to be valued at US$ 1.2 Billion in 2025 and is expected to exhibit a CAGR of 15% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the digital breast tomosynthesis equipment market are Hologic Inc., Siemens Healthineers, Fujifilm Holdings Corporation, GE Healthcare, and Planmed Oy. Hologic Inc. is one of the leading players in the DBT market, accounting for over 50% of the global market share.
The rising incidences of breast cancer across the globe is a major factor driving the demand for DBT equipment. According to the World Health Organization (WHO), breast cancer is the most commonly occurring cancer in women worldwide. Early detection through advanced imaging modalities can significantly improve the survival rates.
Technological advancements have further enhanced the clinical applications of DBT systems. Newer systems offer features such as 3D Rendering, Artificial Intelligence (AI) enabled tools for improved clinical workflow and automated breast density assessment. Vendors are also focused on developing mobile solutions to enable portable breast cancer screening in remote areas.
Market Trends
Integration with Artificial Intelligence - Major DBT vendors are integrating AI and machine learning capabilities into their solutions. AI assists in automated image reconstruction, prioritization of images for radiologist review, and providing quantitative measurements for analysis.
Mobile Testing Solutions - Compact and portable DBT units are being developed to enable screening in remote populations. Mobile vans equipped with DBT can improve access to breast cancer diagnosis in rural areas.
Combination Systems - Combination units integrating DBT with ultrasound or MRI into a single workflow are gaining traction. Combined modalities provide improved lesion characterization within a single exam.
Market Opportunities
Emerging Markets - Markets in Asia Pacific, Latin America, Middle East and Africa represent major growth opportunities for DBT vendors. Increasing healthcare expenditures and expanding insurance coverage will drive the adoption.
Replacement of Existing Systems - As older 2D mammography equipment reaches the end of their lifespan, there will be opportunities for DBT vendors to replace them. Around 20-30% of existing units are due for replacement globally each year.
Adjunct to Ultrasound - There is potential to increase the utilization of DBT as an adjunct imaging tool for evaluating lesions initially detected on ultrasound. This represents an additional application area.
Impact of COVID-19 on Digital Breast Tomosynthesis Equipment Market:
The COVID-19 pandemic has significantly impacted the growth of digital breast tomosynthesis equipment market globally. During the initial lockdown phases in early 2020, hospitals and diagnostic centers focused their resources on COVID-19 patients which resulted in postponing of non-urgent diagnostic procedures like mammography. This led to a decline in the demand for digital breast tomosynthesis equipment from end users in 2020. However, as lockdowns eased in several countries from mid-2020, the demand started reviving as healthcare facilities gradually resumed their normal operations while following necessary safety protocols.
Despite the initial slump, the long term growth prospects for this market remain positive. With rising breast cancer incidence rates worldwide, screening and detection is gaining more focus. Digital breast tomosynthesis provides more accurate imaging compared to traditional 2D mammography and its usage is growing significantly. Equipment manufacturers are introducing new advanced systems with improved features to leverage this opportunity. Telehealth is also playing a role where clinicians can review scans remotely and provide second opinions to expand access. Governments in several countries announced funding to improve cancer diagnostic infrastructure which will also support market growth post pandemic. While short term disruptions occurred, focus on early detection makes digital breast tomosynthesis an essential part of quality cancer care in the new normal.
North America regional market:
North America currently accounts for the largest share of the global digital breast tomosynthesis equipment market in terms of value. This is attributed to factors like growing breast cancer prevalence, favorable reimbursement policies, technology advancements and greater awareness about importance of early detection. The United States dominates the North America regional market with a high installed base of digital breast tomosynthesis systems across hospitals and diagnostic centers.
Asia Pacific regional market:
The Asia Pacific region is poised to be the fastest growing regional market for digital breast tomosynthesis equipment during the forecast period. This is due to rising healthcare expenditures, increasing focus on women's health and growing medical tourism in countries like China, India and South Korea. Governments in several Asia Pacific countries have launched national breast cancer screening programs which is supporting the adoption of digital breast tomosynthesis systems. Moreover, presence of untapped opportunities and lower equipment prices are encouraging manufacturers to expand in Asia Pacific.

Get More Insights On- Digital Breast Tomosynthesis Equipment Market

Get this Report in Japanese Language: デジタル乳房トモシンセシス装置市場

Get this Report in Korean Language: ぢ 기타 l B 희귀 st 모두 syn s s

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)